Outlandish claims of effortless weight loss and reversal of diabetes with no side effects should be met with extreme skepticism, especially when not evaluated and approved by reputable regulatory agencies like the FDA, or backed by peer-reviewed clinical research
Market impact and costs Global GLP-1 sales exceeded $41B in 2024 and are expected to triple by 2030, according to industry reports
Hojjat provides treatments that help patients look and feel like the best version of themselves
Disclaimers & Attributions Brand References: Ozempic and Wegovy are registered trademarks of Novo Nordisk A/S
There's way less deciphering to do here, and the mechanism and dosing check out
For context, bariatric surgery typically results in 2530% weight loss, making retatrutide potentially competitive with surgical outcomesbut without the scalpel